Neoadjuvant TACiE in Locally Advanced Gastric Cancer
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, single-arm, phase 2 trial to evaluate the feasibility
and safety of neoadjuvant transcatheter infusion and embolism (TACiE) in patients with
locally advanced adenocarcinoma of stomach and gastroesophageal junction.
The TACiE protocol includes four cycles. Transcatheter oxaliplatin and concurrent embolism on
day 1 and oral S-1 on day 1-14 will be administrated in the first and third cycles.
Intra-venous oxaliplatin on day 1 and oral S-1 on day 1-14 (SOX) will be administrated in the
second and fourth cycles.